42 research outputs found
Responding to the Event Deluge
We present the VOEventNet infrastructure for large-scale rapid follow-up of
astronomical events, including selection, annotation, machine intelligence, and
coordination of observations. The VOEvent standard is central to this vision,
with distributed and replicated services rather than centralized facilities. We
also describe some of the event brokers, services, and software that are
connected to the network. These technologies will become more important in the
coming years, with new event streams from Gaia, LOFAR, LIGO, LSST, and many
others.Comment: Submitted to Proceedings of SPIE Observatory Operations, Amsterdam,
2012 July 2-
Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania
Previous work from our group showed that tamoxifen, an oral drug that has been in use for the treatment of breast cancer for over 40 years, is active both in vitro and in vivo against several species of Leishmania, the etiological agent of leishmaniasis. Using a combination of metabolic labeling with [3H]-sphingosine and myo-[3H]-inositol, alkaline hydrolysis, HPTLC fractionations and mass spectrometry analyses, we observed a perturbation in the metabolism of inositolphosphorylceramides (IPCs) and phosphatidylinositols (PIs) after treatment of L. amazonensis promastigotes with tamoxifen, with a significant reduction in the biosynthesis of the major IPCs (composed of d16:1/18:0-IPC, t16:0/C18:0-IPC, d18:1/18:0-IPC and t16:0/20:0-IPC) and PIs (sn-1-O-(C18:0)alkyl -2-O-(C18:1)acylglycerol-3-HPO4-inositol and sn-1-O-(C18:0)acyl-2-O-(C18:1)acylglycerol-3-HPO4-inositol) species. Substrate saturation kinetics of myo-inositol uptake analyses indicated that inhibition of inositol transport or availability were not the main reasons for the reduced biosynthesis of IPC and PI observed in tamoxifen treated parasites. An in vitro enzymatic assay was used to show that tamoxifen was able to inhibit the Leishmania IPC synthase with an IC50 value of 8.48 μM (95% CI 7.68–9.37), suggesting that this enzyme is most likely one of the targets for this compound in the parasites